Latest Announcements

Sambhv Steel Tubes Limited clarifies the Corrigendum dated July 28, 2026, to the Extraordinary General Meeting Notice, specifically clarifying the amounts set out in the table under Point No. (vi) of Item No. 1 of the Explanatory Statement titled "Purpose/Objects of the Issue and aggregate amount proposed to be raised".

Gabriel India Limited has informed the Exchange about Revision in Credit Rating of the Company, with Crisil Ratings Limited revising and upgrading the Credit Rating to AA+/Stable from AA/Stable.

Gabriel India Ltd has announced a revision in its credit rating, upgraded by Crisil Ratings Limited from AA/Stable to AA+/Stable for its long-term bank facilities. The revised rating is available on Crisil's website and the company's website.

MTAR Technologies Limited has presented its investor presentation, highlighting its focus on indigenisation of critical technologies, revenue growth of 80% for the current fiscal year, and expansion into emerging opportunities such as data centre infrastructure solutions.

MTAR Technologies Ltd presented its investor presentation for July 2026, highlighting its focus on indigenising critical technologies in strategic sectors, with a revenue growth of 80% guided for the current fiscal year and an EBITDA margin of 24% ±100 bps.

Honeywell Automation India Limited has revised its notice of the 42nd Annual General Meeting (AGM) due to a typo in the previously submitted Annual Report. The corrected version is now available on the company's website.

Capital Trade Links Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 01/08/2026 to consider and approve financial results for the quarter ended 30/06/2026.

RPG Life Sciences Ltd has announced a strategic API initiative to accelerate its next phase of growth. The company will transfer its API business to a wholly owned subsidiary, RPG Active Pharma, and raise an initial amount of up to INR 243 crore from funds managed by InvAscent. RPG Active Pharma will also acquire 100% equity share capital of Actis Generics Private Limited.

RPG Life Sciences Limited has announced a strategic API initiative to accelerate its next phase of growth. The company has executed an agreement to transfer its API business to its wholly owned subsidiary, RPG Active Pharma Limited, and will raise an initial amount of up to INR 243 crore from funds managed by Inv Ascent. RPG Active Pharma will also acquire 100% equity share capital of Actis Generics Private Limited.

Cholamandalam Investment and Finance Company Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on July 28, 2026. The company has informed the Exchange regarding voting results, with all resolutions passed by the shareholders with the requisite majority.

Cholamandalam Investment and Finance Company Ltd has announced the voting results and scrutinizer report for its 48th Annual General Meeting (AGM) held on July 28, 2026. All the resolutions were passed with the requisite majority. The company has also confirmed the interim and final dividend for the financial year ended March 31, 2026.

RPG Life Sciences Ltd has announced the execution of a Business Transfer Agreement for the sale of its Active Pharmaceutical Ingredients (API) business to its wholly-owned subsidiary, RPG Active Pharma Limited, for Rs. 33.55 crore. The sale is expected to be completed by September 30, 2026, subject to customary conditions.

RPG Life Sciences Limited has announced the execution of a Business Transfer Agreement for the sale of its Active Pharmaceutical Ingredients (API) business to its wholly-owned subsidiary, RPG Active Pharma Limited, for a consideration of Rs. 33.55 crore. The sale is expected to be completed by September 30, 2026, subject to customary conditions.

RPG Life Sciences Limited has executed a Business Transfer Agreement for the sale of its Active Pharmaceutical Ingredients (API) business to RPG Active Pharma Limited, a wholly-owned subsidiary, for Rs. 33.55 crore. The sale is expected to be completed by September 30, 2026. The transaction is a related-party transaction done at arm's length and is outside the Scheme of Arrangement.

RPG Life Sciences Ltd has executed a Business Transfer Agreement for the sale of its Active Pharmaceutical Ingredients (API) business to its wholly owned subsidiary, RPG Active Pharma Limited, for a consideration of Rs. 33.55 crore. The sale is expected to be completed by September 30, 2026.

Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the voluntary liquidation of its wholly-owned subsidiary MHC Global Healthcare (Nigeria) Limited.

Max Healthcare Institute Ltd has informed that its wholly-owned subsidiary MHC Global Healthcare (Nigeria) Ltd has been voluntarily wound up and dissolved in Nigeria, with no material impact on the company's financials.

RPG Life Sciences Limited has announced the outcome of its Board Meeting held on July 29, 2026, where it considered and approved the execution of Business Transfer Agreement for the sale of its Active Pharmaceutical Ingredients (API) business to RPG Active Pharma Limited, a wholly owned subsidiary. The sale is expected to be completed on or before September 30, 2026.

RPG Life Sciences Ltd has announced the outcome of its board meeting, where it approved the execution of a business transfer agreement for the sale of its API business to its wholly-owned subsidiary, RPG Active Pharma Limited, for a consideration of Rs. 33.55 crore. The sale is expected to be completed by September 30, 2026.

Honeywell Automation India Ltd has submitted its revised Annual Report for FY 2025-26, correcting a typo on page 16 regarding commission payable to Independent Directors, with no other changes.